The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review
Abstract Background An emerging public health threat of methamphetamine/opioid co-use is occurring in North America, including increases in overdoses related to concomitant methamphetamine/opioid use. This presents a potential risk to established treatments for opioid use disorder (i.e., medications...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-08-01
|
| Series: | Addiction Science & Clinical Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13722-023-00402-0 |
| _version_ | 1797557347062644736 |
|---|---|
| author | Cayley Russell Justine Law Sameer Imtiaz Jürgen Rehm Bernard Le Foll Farihah Ali |
| author_facet | Cayley Russell Justine Law Sameer Imtiaz Jürgen Rehm Bernard Le Foll Farihah Ali |
| author_sort | Cayley Russell |
| collection | DOAJ |
| description | Abstract Background An emerging public health threat of methamphetamine/opioid co-use is occurring in North America, including increases in overdoses related to concomitant methamphetamine/opioid use. This presents a potential risk to established treatments for opioid use disorder (i.e., medications for opioid use disorder [MOUD]). To date, few studies have examined the impact of methamphetamine use on MOUD-related outcomes, and no studies have synthesized data on MOUD retention. Methods A scoping review was undertaken to examine the impact of methamphetamine use on MOUD retention. All original published research articles were searched in Embase, MEDLINE, PsychINFO, CINAHL, Scopus, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Cochrane Protocols, and Google scholar databases. Data were extracted into a standardized data extraction chart. Findings were presented narratively. Results All eight included studies demonstrated an increased likelihood of treatment discontinuation or dropout among patients enrolled in MOUD who used methamphetamine. The frequency of methamphetamine use was also associated with MOUD dropout, in that those who used methamphetamine more often were more likely to discontinue MOUD. The definitions and measurements of MOUD retention varied considerably, as did the magnitude of effect size. Conclusions Results indicate that methamphetamine use has an undesirable impact on MOUD retention and results in an increased risk of treatment discontinuation or dropout. Strategies to identify concurrent methamphetamine use among individuals engaging in MOUD and educate them on the increased risk for dropout should be undertaken. Further research is needed to understand how MOUD retention among patients with concomitant opioid and methamphetamine use can be improved. |
| first_indexed | 2024-03-10T17:15:52Z |
| format | Article |
| id | doaj.art-048d39c7f9b444bca7db4a7b00825910 |
| institution | Directory Open Access Journal |
| issn | 1940-0640 |
| language | English |
| last_indexed | 2024-03-10T17:15:52Z |
| publishDate | 2023-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Addiction Science & Clinical Practice |
| spelling | doaj.art-048d39c7f9b444bca7db4a7b008259102023-11-20T10:28:50ZengBMCAddiction Science & Clinical Practice1940-06402023-08-0118111410.1186/s13722-023-00402-0The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping reviewCayley Russell0Justine Law1Sameer Imtiaz2Jürgen Rehm3Bernard Le Foll4Farihah Ali5Centre for Addiction and Mental Health (CAMH) & Ontario Node, Institute for Mental Health Policy Research, Canadian Research Initiative in Substance Misuse (CRISM)Centre for Addiction and Mental Health (CAMH) & Ontario Node, Institute for Mental Health Policy Research, Canadian Research Initiative in Substance Misuse (CRISM)Centre for Addiction and Mental Health (CAMH) & Ontario Node, Institute for Mental Health Policy Research, Canadian Research Initiative in Substance Misuse (CRISM)Centre for Addiction and Mental Health (CAMH) & Ontario Node, Institute for Mental Health Policy Research, Canadian Research Initiative in Substance Misuse (CRISM)Department of Psychiatry, University of TorontoCentre for Addiction and Mental Health (CAMH) & Ontario Node, Institute for Mental Health Policy Research, Canadian Research Initiative in Substance Misuse (CRISM)Abstract Background An emerging public health threat of methamphetamine/opioid co-use is occurring in North America, including increases in overdoses related to concomitant methamphetamine/opioid use. This presents a potential risk to established treatments for opioid use disorder (i.e., medications for opioid use disorder [MOUD]). To date, few studies have examined the impact of methamphetamine use on MOUD-related outcomes, and no studies have synthesized data on MOUD retention. Methods A scoping review was undertaken to examine the impact of methamphetamine use on MOUD retention. All original published research articles were searched in Embase, MEDLINE, PsychINFO, CINAHL, Scopus, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Cochrane Protocols, and Google scholar databases. Data were extracted into a standardized data extraction chart. Findings were presented narratively. Results All eight included studies demonstrated an increased likelihood of treatment discontinuation or dropout among patients enrolled in MOUD who used methamphetamine. The frequency of methamphetamine use was also associated with MOUD dropout, in that those who used methamphetamine more often were more likely to discontinue MOUD. The definitions and measurements of MOUD retention varied considerably, as did the magnitude of effect size. Conclusions Results indicate that methamphetamine use has an undesirable impact on MOUD retention and results in an increased risk of treatment discontinuation or dropout. Strategies to identify concurrent methamphetamine use among individuals engaging in MOUD and educate them on the increased risk for dropout should be undertaken. Further research is needed to understand how MOUD retention among patients with concomitant opioid and methamphetamine use can be improved.https://doi.org/10.1186/s13722-023-00402-0North AmericaMethamphetamineMedications for opioid use disorderOpioid agonist treatmentOpioid use disorderTreatment retention |
| spellingShingle | Cayley Russell Justine Law Sameer Imtiaz Jürgen Rehm Bernard Le Foll Farihah Ali The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review Addiction Science & Clinical Practice North America Methamphetamine Medications for opioid use disorder Opioid agonist treatment Opioid use disorder Treatment retention |
| title | The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review |
| title_full | The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review |
| title_fullStr | The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review |
| title_full_unstemmed | The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review |
| title_short | The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review |
| title_sort | impact of methamphetamine use on medications for opioid use disorder moud treatment retention a scoping review |
| topic | North America Methamphetamine Medications for opioid use disorder Opioid agonist treatment Opioid use disorder Treatment retention |
| url | https://doi.org/10.1186/s13722-023-00402-0 |
| work_keys_str_mv | AT cayleyrussell theimpactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT justinelaw theimpactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT sameerimtiaz theimpactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT jurgenrehm theimpactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT bernardlefoll theimpactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT farihahali theimpactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT cayleyrussell impactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT justinelaw impactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT sameerimtiaz impactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT jurgenrehm impactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT bernardlefoll impactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview AT farihahali impactofmethamphetamineuseonmedicationsforopioidusedisordermoudtreatmentretentionascopingreview |